Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$25.68 - $35.59 $68,231 - $94,562
-2,657 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$24.9 - $40.26 $66,159 - $106,970
2,657 New
2,657 $78,000
Q1 2021

May 04, 2021

SELL
$38.94 - $50.85 $756,059 - $987,303
-19,416 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$37.65 - $63.77 $731,012 - $1.24 Million
19,416 New
19,416 $841,000
Q3 2020

Nov 03, 2020

SELL
$52.76 - $74.49 $720,279 - $1.02 Million
-13,652 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$48.73 - $81.82 $665,261 - $1.12 Million
13,652 New
13,652 $862,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.